Table 1 Characteristics of patients (N = 216)
No VTE | VTE | Total | P-value | |||
|---|---|---|---|---|---|---|
N | % | N | % | N | ||
Age, median (range) | ||||||
< 70 years | 113 | 75.3 | 37 | 24.7 | 150 | 0.425 |
≥ 70 years | 53 | 80.3 | 13 | 19.7 | 66 | |
Sex | ||||||
Male | 108 | 82.4 | 23 | 17.6 | 131 | 0.016 |
Female | 58 | 68.2 | 27 | 31.8 | 85 | |
BSA | ||||||
< 1.8 m2 | 153 | 78.1 | 43 | 21.9 | 196 | 0.187 |
≥ 1.8 m2 | 13 | 65 | 7 | 35 | 20 | |
BMI | ||||||
< 30 kg/m2 | 162 | 77.1 | 48 | 22.9 | 210 | 0.549 |
≥ 30 kg/m2 | 4 | 66.7 | 2 | 33.3 | 6 | |
DM | ||||||
No | 90 | 73.2 | 33 | 26.8 | 123 | 0.14 |
Yes | 76 | 81.7 | 17 | 18.3 | 93 | |
Site of primary mass: | ||||||
Head | 80 | 79.2 | 21 | 20.8 | 101 | 0.506 |
Body | 28 | 80 | 7 | 20 | 35 | |
Tail | 58 | 72.5 | 22 | 27.5 | 80 | |
Previous surgery: | ||||||
Palliative | 10 | 83.3 | 2 | 16.7 | 12 | 0.584 |
None | 156 | 76.5 | 48 | 23.5 | 204 | |
ECOG PS | ||||||
0–1 | 150 | 76.5 | 46 | 23.5 | 196 | 0.726 |
2–3 | 16 | 80 | 4 | 20 | 20 | |
WBC | ||||||
< 11,000/μL | 136 | 75.1 | 45 | 24.9 | 181 | 0.174 |
≥ 11,000/μL | 30 | 85.7 | 5 | 14.3 | 35 | |
Hb | ||||||
< 10 g/dL | 31 | 68.9 | 14 | 31.1 | 45 | 0.404 |
≥ 10 g/dL | 193 | 74.8 | 65 | 25.2 | 258 | |
PLT | 0.091 | |||||
< 350,000/μL | 148 | 78.7 | 40 | 21.3 | 188 | |
≥ 350,000/μL | 18 | 64.3 | 10 | 35.7 | 28 | |
CA19–9 | ||||||
< 1000 U/mL | 88 | 75.2 | 29 | 24.8 | 117 | 0.535 |
≥ 1000 U/mL | 78 | 78.8 | 21 | 21.2 | 99 | |
Khorana score | ||||||
Intermediate–risk (2) | 105 | 77.8 | 30 | 22.2 | 135 | 0.677 |
High-risk (≥3) | 61 | 75.3 | 20 | 24.7 | 81 | |
CVC insertion | ||||||
No | 32 | 69.6 | 14 | 30.4 | 46 | 0.219 |
Yes | 133 | 78.2 | 37 | 21.8 | 170 | |
Chemotherapy more than first-line | ||||||
≥ Second-line | 68 | 81 | 16 | 19 | 84 | 0.205 |
First-line only | 88 | 72.7 | 33 | 27.3 | 121 | |
Unknown | 10 | 90.9 | 1 | 9.1 | 11 | |
Number of metastatic organs | ||||||
< 3 | 40 | 85.1 | 7 | 14.9 | 47 | 0.129 |
≥ 3 | 126 | 74.6 | 43 | 25.4 | 169 | |